Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
we didn receive our second dose until 12/11/2021; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 19-JUN-2018). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: we didn receive our second dose until 12/11/2021). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 06-MAY-2025 The reporter reported that a patient received first dose of the Shingrix vaccine on 19-JUN-2018. The reporter understand the next dose is recommended to be 2 to 6 months apart. For some reason that it might have been availability and then forgetfulness, did not receive our second dose until 11-DEC-2021. The reporter was ask the effectiveness of the timing of these two doses. This case is linked with US2025AMR057409, reported by same reporter. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.; Sender's Comments: US-GSK-US2025AMR057409:same reporter different patient